Finance, Geography, Planning and Development, Economics, Econometrics and Finance
23
Scopus Publications
1316
Scholar Citations
20
Scholar h-index
32
Scholar i10-index
Scopus Publications
Predictors of Return to Work After Stroke in Hungary: A Mixed-Methods Economic and Clinical Data Analysis Arie Arizandi Kurnianto, Sándor Kovács, Nagy Ágnes Healthcare Switzerland, 2025 Background: Return to work (RTW) is a fundamental aspect of recovery after stroke, importantly, for workers of working age. Evidence indicates there is little known about the clinical and systematic predictors of RTW in Hungary. We aimed to determine the independent predictors of RTW for stroke survivors using aggregate hospital data and expert opinion. Methods: A mixed-method study using aggregated national level administrative data from the Pulvita platform (the National Health Insurance Fund of Hungary) and expert interpretation from the physicians who treat stroke survivors. The data analyzed 13,572 inpatient records for stroke hospitalizations from 2015–2024 across Hungarian counties. Results: Stroke severity, cognitive and psychological recovery, and presence of comorbidities were important clinical predictors of RTW. Rehabilitation intensity was greater for people aged 51–65 years, and work-age men appeared to have slightly better access to rehabilitation compared to work-aged women. Patients accessed more medical rehabilitation services than they did occupational or psychosocial services. Access to rehabilitation services may have varied geographically, with patients in counties such as Budapest and Pest having better access due to higher provider availability and cross-county patient movement. In addition, economic extrapolations from the literature on post-stroke care costs may have introduced bias in estimating annual social productivity losses, reported as EUR 19,953 per patient. Conclusions: Clinical and economic factors both impact RTW potential among stroke survivors in Hungary. Although rehabilitation intensity can indicate likelihood of RTW, the lack of a national RTW program acts as a significant barrier to RTW for stroke survivors. This study suggests a need for integrated rehabilitation and RTW systems, with associated future research linking clinical, economic, and labor market status data to develop effective and efficient policy for stroke survivors.
Economic Evaluations of Rehabilitation Interventions: A Scoping Review with Implications for Return to Work Programs Arie Arizandi Kurnianto, Sándor Kovács, Nagy Ágnes, Prabhat Kumar Healthcare Switzerland, 2025 Background/Objectives: The use of rehabilitation interventions is critical in addressing health and economic outcomes, including return to work (RTW) facilitation for individuals with disabilities. However, the economic evaluation of these interventions has been found to lack consistency, with limited adherence to reporting standards and little focus on integrated approaches. This scoping review will map the existing evidence on the economic evaluations of rehabilitation interventions and their implications for return to work (RTW) programs. Methods: A systematic search of databases, such as PubMed, Scopus, and Web of Science, to identify studies that provided full economic evaluations of rehabilitation interventions related to RTW. Using the PRISMA-ScR framework, 11 studies were ultimately included. Data extraction included the model type, cost-effectiveness models, adherence to CHEERS reporting guidelines, and implications for RTW. Results: The majority of studies examined medical or psychological interventions, with little representation of vocational or integrated approaches. ICERs differed greatly between studies based on methodologies and healthcare settings. The reporting of heterogeneity, uncertainty analysis, and societal perspectives were some of the gaps identified from adherence to CHEERS guidelines. Conclusions: Economic evaluations show that rehabilitation interventions can be cost-effective for improving RTW outcomes. Future research priorities include interdisciplinary approaches, standardized methodologies, and studies based on LMICs to address global disparities.
Patient-Reported Experience and Outcome Measures of Patients Living With Diabetes: Associations Among Different Factors Eszter Sághy, Dalma Erdősi, Bertalan Németh, Sándor Kovács, István Wittmann, Antal Zemplényi Value in Health Regional Issues, 2025 OBJECTIVES: This study aimed to explore the association between demographic characteristics and patient-reported experiences (PREs) and patient-reported outcomes (PROs) in individuals living with diabetes, using the Swedish National Diabetes Register questionnaire. The study sought to understand how baseline attributes such as age, gender, and education affect patients' experiences and management of diabetes. METHODS: We used a cross-sectional survey approach with 544 patients diagnosed as having type 1 or type 2 diabetes mellitus at the University of Pécs. An exploratory factor analysis was conducted to identify the key dimensions of diabetes-related experiences, followed by a confirmatory factor analysis to validate these dimensions. Regression analysis was used to examine the impact of demographic variables on the derived factors. RESULTS: The factor analysis revealed 5 key dimensions: diabetes-related obstacles, diabetes coping mechanisms, flexibility of healthcare providers, general well-being, and social support. Regression analysis indicated that older patients perceived fewer obstacles and demonstrated better coping mechanisms. Higher educational levels were significantly associated with greater satisfaction with healthcare provider flexibility. Females reported poorer overall well-being but better coping mechanisms than males. CONCLUSIONS: The findings suggest that demographic characteristics significantly influence patient experiences and outcomes in diabetes care. Tailored interventions that address specific demographic needs can enhance patient-centered care and improve management strategies. These insights underscore the importance of considering patient diversity in developing healthcare interventions and underscore the utility of the Swedish National Diabetes Register questionnaire in assessing diverse patient experiences in diabetes management.
A novel machine learning methodology for the systematic extraction of chronic kidney disease comorbidities from abstracts Eszter Sághy, Mostafa Elsharkawy, Frank Moriarty, Sándor Kovács, István Wittmann, Antal Zemplényi Frontiers in Digital Health, 2025 BackgroundChronic Kidney Disease (CKD) is a global health concern and is frequently underdiagnosed due to its subtle initial symptoms, contributing to increasing morbidity and mortality. A comprehensive understanding of CKD comorbidities could lead to the identification of risk-groups, more effective treatment and improved patient outcomes. Our research presents a two-fold objective: developing an effective machine learning (ML) workflow for text classification and entity relation extraction and assembling a broad list of diseases influencing CKD development and progression.MethodsWe analysed 39,680 abstracts with CKD in the title from the Embase library. Abstracts about a disease affecting CKD development and/or progression were selected by multiple ML classifiers trained on a human-labelled sample. The best classifier was further trained with active learning. Disease names in question were extracted from the selected abstracts using a novel entity relation extraction methodology. The resulting disease list and their corresponding abstracts were manually checked and a final disease list was created.FindingsThe SVM model gave the best results and was chosen for further training with active learning. This optimised ML workflow enabled us to discern 68 comorbidities across 15 ICD-10 disease groups contributing to CKD progression or development. The reading of the ML-selected abstracts showed that some diseases have direct causal effect on CKD, while others, like schizophrenia, has indirect causal effect on CKD.InterpretationThese findings have the potential to guide future CKD investigations, by facilitating the inclusion of a broader array of comorbidities in CKD prognostic models. Ultimately, our study enhances understanding of prognostic comorbidities and supports clinical practice by enabling improved patient monitoring, preventive strategies, and early detection for individuals at higher CKD development or progression risk.
Optimization of pharmaceutical research and development by early-phase assessment of investigational medicinal products Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy British Journal of Clinical Pharmacology, 2025 Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations. Limited attention to building the health economic story during early development phases may ultimately result in suboptimal return on investment. Early‐phase health technology assessment (eHTA) provides a structured approach to value maximization. Selection of the payment model helps to understand what value propositions are taken into account, in general, by the target payers of the new medicine. Fair judgement on the degree of innovation at the expected launch date is essential to choose the relevant propositions from the general list of value drivers. Development of the conceptual value framework translates target product profile into policy‐relevant value propositions, such as health gain, expected cost savings through avoided medical events and delayed disease progression, value in use or health system benefits. Implementation of the health economics and outcomes research strategy helps to justify premium price based on added value and facilitate the appropriate order of target indications with the most return on investment. Effective integration of eHTA into the research and development process enables innovators to shorten time to reimbursement and increases the probability of clinical and commercial success for investigational medicinal products.
Incidence of staphylococcus aureus infections after surgical interventions: a systematic review and meta-analysis Baher Elezbawy, Nada Abaza, Mirna Fasseeh, Rawda Elshahawy, Yosra S. Mahmoud, Hassan Hendawy, Sergey R. Konstantinov, Javier Ruiz-Guiñazú, Corinne Willame, Jeroen Geurtsen, Jan Poolman, Zoltán Voko, Dávid Nagy, Tamás Zelei, Sándor Kovács, Szimonetta Lohner Expert Review of Anti Infective Therapy, 2025 INTRODUCTION: Postoperative Staphylococcus aureus (S. aureus) infections are associated with increased morbidity and mortality. This systematic review and meta-analysis aimed to summarize the incidence of postoperative S. aureus infections. METHODS: We searched MEDLINE, CENTRAL, and Embase (2008-2023) for studies reporting S. aureus infections after hip or knee replacement, spinal surgery, craniotomy, coronary artery bypass surgery (CABG), open colon surgery, abdominal hysterectomy, cesarean section, peripheral vascular bypass, or elective plastic surgery in selected developed countries were considered. We conducted meta-analysis with a generalized linear mixed model and assessed risk of bias. This study is registered with PROSPERO,CRD42023416876. RESULTS: Data from 224 studies indicated a cumulative incidence of deep S. aureus infection after hip surgery 5.05 infections/1000 procedures (95% CI 3.29-7.74), 5.59 (95% CI 3.62-8.63) after knee surgery, 11.74 (95% CI 9.08-15.16) after spinal surgery, and 7.23 (95% CI 1.63-31.86) after CABG surgery. S. aureus infections were associated with increased all-cause mortality among CABG, hip, knee, and spinal surgeries. Patients cohorts who received antibiotic prophylaxis and/or underwent decolonization demonstrated lower incidence of S. aureus infections. CONCLUSIONS: The incidence of S. aureus infections varies by procedure, with highest rates seen after spinal surgeries and hysterectomies. Findings highlight the importance of standardized prevention across surgical settings.
Breast cancer stage and molecular subtype distribution: real-world insights from a regional oncological center in Hungary Judit Tittmann, Tamás Ágh, Dalma Erdősi, Bettina Csanády, Erika Kövér, Antal Zemplényi, Sándor Kovács, Zoltán Vokó Discover Oncology, 2024 Objective Examining the distribution of breast cancer (BC) stage and molecular subtype among women aged below (< 45 years), within (45–65 years), and above (> 65 years) the recommended screening age range helps to understand the screening program's characteristics and contributes to enhancing the effectiveness of BC screening programs. Methods In this retrospective study, female patients with newly diagnosed BC from 2010 to 2020 were identified. The distribution of cases in terms of TNM stages, severity classes, and subtypes was analysed according to age groups. Results A total of 3282 women diagnosed with BC were included in the analysis. Among these cases 51.4% were detected outside the screening age group, and these were characterized by a higher TNM stage compared to those diagnosed within the screening age band. We observed significantly higher relative frequency of advanced BC in the older age group compared to both the screening age population and women younger than 45 years (14.9% vs. 8.7% and 7.7%, P < 0.001). HR−/HER2− and HER+ tumours were relatively more frequent among women under age 45 years (HR−/HER2−: 23.6%, HER2+: 20.5%) compared to those within the screening age range (HR−/HER2−: 13.4%, HER2+: 13.9%) and the older age group (HR−/HER2−: 10.4%, HER2+: 11.5%). Conclusions The findings of our study shed light on potential areas for the improvement of BC screening programs (e.g., extending screening age group, adjusting screening frequency based on molecular subtype risk status) in Hungary and internationally, as well.
Mapping Hungarian procedure codes to SNOMED CT Ágota Mészáros, Sándor Kovács, Tibor Héja, Zsolt Bagyura, Antal Zemplényi BMC Medical Research Methodology, 2023 Background Data harmonisation is essential in real-world data (RWD) research projects based on hospital information systems databases, as coding systems differ between countries. The Hungarian hospital information systems and the national claims database use internationally known diagnosis codes, but data on medical procedures are recorded using national codes. There is no simple or standard solution for mapping the national codes to a standard coding system. Our aim was to map the Hungarian procedure codes (OENO) to SNOMED CT as part of the European Health Data Evidence Network (EHDEN) project. Methods We recruited 25 professionals from different specialties to manually map the procedure codes used between 2011 and 2021. A mapping protocol and training material were developed, results were regularly revised, and the challenges of mapping were recorded. Approximately 7% of the codes were mapped by more people in different specialties for validation purposes. Results We mapped 4661 OENO codes to standard vocabularies, mostly SNOMED CT. We categorized the challenges into three main areas: semantic, matching, and methodological. Semantic refers to the occasionally unclear meaning of the OENO codes, matching to the different granularity and purpose of the OENO and SNOMED CT vocabularies. Lastly, methodological challenges were used to describe issues related to the design of the above-mentioned two vocabularies. Conclusions The challenges and solutions presented here may help other researchers to design their process to map their national codes to standard vocabularies in order to achieve greater consistency in mapping results. Moreover, we believe that our work will allow for better use of RWD collected in Hungary in international research collaborations.
Efficacy of repetitive transcranial magnetic stimulation (rTMS) adjunctive therapy for major depressive disorder (MDD) after two antidepressant treatment failures: meta-analysis of randomized sham-controlled trials Róbert György Vida, Eszter Sághy, Richárd Bella, Sándor Kovács, Dalma Erdősi, Judit Józwiak-Hagymásy, Antal Zemplényi, Tamás Tényi, Péter Osváth, Viktor Voros BMC Psychiatry, 2023 Background Several meta-analyses demonstrated the efficacy of unilateral High-Frequency Left-sided (HFL) repetitive Transcranial Magnetic Stimulation (rTMS) for individuals with Major Depressive Disorder (MDD); however, results are contradictory due to heterogeneity of the included studies. Methods A systematic literature review (SLR) of English language articles published since 2000 was performed in March 2022 on PubMed and Scopus databases. Empirical evidence on the relative efficacy of rTMS treatment compared with standard pharmacotherapy in Treatment-Resistant Depression (TRD) were extracted. Random effects models were used to assess the effects of rTMS on response and remission rates. Results 19 randomized double-blinded sham-controlled studies were included for quantitative analysis for response (n = 854 patients) and 9 studies for remission (n = 551 patients). The risk ratio (RR) for response and remission are 2.25 and 2.78, respectively for patients after two treatment failures using rTMS as add-on treatment compared to standard pharmacotherapy. Cochrane’s Q test showed no significant heterogeneity. No publication bias was detected. Conclusions rTMS is significantly more effective than sham rTMS in TRD in response and remission outcomes and may be beneficial as an adjunctive treatment in patients with MDD after two treatment failures. This finding is consistent with previous meta-analyses; however, the effect size was smaller than in the formerly published literature.
Systematic literature review of the epidemiology of glycogen storage disease type 1a Tamás Zelei, Sándor Kovács, Patrick Finn, Dávid Nagy, Vanja Sikirica, Katherine B. Carlson, Zoltán Vokó Journal of Pediatric Endocrinology and Metabolism, 2023 Glycogen storage disease (GSD) type 1a is an inherited autosomal recessive metabolic disease caused by a deficiency in glucose-6-phosphatase activity. The objectives of this research were to systematically review the published literature on the epidemiology of GSD 1a and to assess the performance of reported epidemiology measures in a simulation model. In this systematic literature review 2,539 record titles and abstracts were screened. Of these, only 11 studies contained relevant data on GSD 1a disease epidemiology. Reported disease frequency ranged from 0.085/100,000 to 10.3/100,000 newborns when considering all the GSD literature. When this was narrowed to GSD 1 and GSD 1a, the range was tightened to 0.25–3.02/100,000 and 0.085–4.9/100,000 newborns, respectively. Most of the identified studies counted the number of diagnoses in a defined period and related to the number of births in the same (Dx method) or different time period (DoB method). The simulation model results indicate that in most of the situations, the Dx method provides a closer estimate to the true disease incidence than the DoB method. Despite the scarcity of epidemiology data, the results of this systematic review strongly support that GSD 1a and its parent disease groups (GSD and GSD 1) are rare diseases.
Quo Vadis HTA for Medical Devices in Central and Eastern Europe? Recommendations to Address Methodological Challenges Rita Daubner-Bendes, Sándor Kovács, Maciej Niewada, Mirjana Huic, Michael Drummond, Oriana Ciani, Carl Rudolf Blankart, Olena Mandrik, Aleksandra Torbica, John Yfantopoulos, Guenka Petrova, Malwina Holownia-Voloskova, Rod S. Taylor, Maiwenn Al, Oresta Piniazhko, László Lorenzovici, Rosanna Tarricone, Antal Zemplényi, Zoltán Kaló Frontiers in Public Health, 2021
A MAGYAR HONVÉDSÉG KIEMELT NEMZETKÖZI GYAKORLATAINAK TERVEZÉSI ÉS LEVEZETÉSI TAPASZTALATAI I Hattyár, S Kovács, S Szabó Honvédségi Szemle–Hungarian Defence Review 153 (5) , 2025 2025
Incidence of staphylococcus aureus infections after surgical interventions: a systematic review and meta-analysis B Elezbawy, N Abaza, M Fasseeh, R Elshahawy, Y S. Mahmoud, ... Expert Review of Anti-infective Therapy 23 (10), 1011-1029 , 2025 2025 Citations: 4
The role of PRLIP2 in the defence and growth of Arabidopsis Insertional mutagenesis of PRLIP2 gene alters hormone balance and defence responses in Arabidopsis S Kovacs, A Nagy, G Major, V Flors, A Rácz, B Mauch-Mani, G Jakab Journal of Plant Physiology, 154609 , 2025 2025 Citations: 3
Predictors of Return to Work After Stroke in Hungary: A Mixed-Methods Economic and Clinical Data Analysis AA Kurnianto, S Kovács, N Ágnes Healthcare 13 (17), 2198 , 2025 2025 Citations: 1
Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products Z Kaló, A Imre, G Varga, S Kovács, G Tímár, B Nagy British Journal of Clinical Pharmacology , 2025 2025 Citations: 1
Economic Evaluations of Rehabilitation Interventions: A Scoping Review with Implications for Return to Work Programs AA Kurnianto, S Kovács, N Ágnes, P Kumar Healthcare 13 (10), 1152 , 2025 2025 Citations: 1
Patient-Reported Experience and Outcome Measures of Patients Living with Diabetes: Associations Among Different Factors E Sághy, D Erdősi, B Németh, S Kovács, I Wittmann, A Zemplényi Value in Health Regional Issues 47, 101082 , 2025 2025 Citations: 2
A novel machine learning methodology for the systematic extraction of chronic kidney disease comorbidities from abstracts E Sághy, M Elsharkawy, F Moriarty, S Kovács, I Wittmann, A Zemplényi Frontiers in digital health 7, 1495879 , 2025 2025 Citations: 1
Nemesi paloták, házak a kolozsvári Belső Közép utcában a 18. században. Adatok egy világi építészeti műfaj kolozsvári történetéhez. K Zsolt Kincses Kolozsvár Kalendáriuma , 2025 2025
Breast cancer stage and molecular subtype distribution: real-world insights from a regional oncological center in Hungary J Tittmann, T Ágh, D Erdősi, B Csanády, E Kövér, A Zemplényi, S Kovács, ... Discover Oncology 15 (1), 240 , 2024 2024 Citations: 8
Certain immune parameters may have a significant impact on suicidal behaviour-a naturalistic study among psychiatric in-patients V Voros, E Saghy, C Molnar, M Kovacs, B Peto, S Kovacs, A Zemplenyi, ... European Psychiatry 67 (S1), S349-S350 , 2024 2024
Adapting and Evaluating the Cost-Effectiveness of the Polish''My Health Everyday''Medication Adherence Coaching Application for Hypertension Management in Hungary D Erdosi, D Karasz, P Kardas, P Lewek, P Klimczak, E Lojewska, ... INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 46 (1), 341-342 , 2024 2024
A gyalui kastély rövid története W Attila, K Zsolt Művelődés , 2024 2024
Csertölgy fizikai vizsgálatai és összehasonlító elemzése a származási körülmények függvényében S Kovács soe , 2024 2024
MT34 Adaptation and Cost-Effectiveness Analysis of the" My Health Everyday” Medication Adherence Coaching Application for Hypertension Management in Hungary D Kárász, D Erdősi, P Kardas, P Lewek, P Klimczak, E Łojewska, ... Value in Health 26 (12), S433 , 2023 2023
Efficacy of repetitive transcranial magnetic stimulation (rTMS) adjunctive therapy for major depressive disorder (MDD) after two antidepressant treatment failures: meta … RG Vida, E Sághy, R Bella, S Kovács, D Erdősi, J Józwiak-Hagymásy, ... BMC psychiatry 23 (1), 1-11 , 2023 2023 Citations: 115
Mapping Hungarian procedure codes to SNOMED CT Á Mészáros, S Kovács, T Héja, Z Bagyura, A Zemplényi BMC Medical Research Methodology 23 (1), 240 , 2023 2023 Citations: 4
Systematic literature review of the epidemiology of glycogen storage disease type 1a T Zelei, S Kovács, P Finn, D Nagy, V Sikirica, KB Carlson, Z Vokó Journal of Pediatric Endocrinology and Metabolism 36 (9), 809-817 , 2023 2023 Citations: 6
Cost-effectiveness analysis of invasive EEG monitoring techniques as a preoperative diagnostic procedure in the planning of resective epilepsy surgery in drug-resistant … S Kovács University of Pécs , 2023 2023
A HPV alapú méhnyakszűrés költség-hasznosság elemzése= Cost-Utility Analysis of the HPV Based Cervical Cancer Screening T Csákvári, S Kovács, D Erdősi, D Pónusz-Kovács, D Elmer, R Vajda, ... ARANYPAJZS: A CSALÁD VÉDELMÉNEK TUDOMÁNYA 2 (2), 28-39 , 2023 2023
MOST CITED SCHOLAR PUBLICATIONS
Efficacy of repetitive transcranial magnetic stimulation (rTMS) adjunctive therapy for major depressive disorder (MDD) after two antidepressant treatment failures: meta … RG Vida, E Sághy, R Bella, S Kovács, D Erdősi, J Józwiak-Hagymásy, ... BMC psychiatry 23 (1), 1-11 , 2023 2023 Citations: 115
Systematic review of real-world studies evaluating the impact of medication non-adherence to endocrine therapies on hard clinical endpoints in patients with non-metastatic … A Inotai, T Ágh, R Maris, D Erdősi, S Kovács, Z Kaló, E Senkus Cancer Treatment Reviews 100, 102264 , 2021 2021 Citations: 91
Surgical outcomes related to invasive EEG monitoring with subdural grids or depth electrodes in adults: a systematic review and meta-analysis M Toth, KS Papp, N Gede, K Farkas, S Kovacs, J Isnard, K Hagiwara, ... Seizure 70, 12-19 , 2019 2019 Citations: 57
Translating scientific knowledge to government decision makers has crucial importance in the management of the COVID-19 pandemic K Gombos, R Herczeg, B Erőss, SZ Kovács, A Uzzoli, T Nagy, S Kiss, ... Population Health Management 24 (1), 35-45 , 2021 2021 Citations: 53
Do existing real-world data sources generate suitable evidence for the HTA of medical devices in Europe? Mapping and critical appraisal B Pongiglione, A Torbica, H Blommestein, S De Groot, O Ciani, S Walker, ... International Journal of Technology Assessment in Health Care 37 (1), e62 , 2021 2021 Citations: 52
A hazai COVID-19-járványhullámok területi különbségei. A Uzzoli, SZ Kovács, B Páger, T Szabó Területi Statisztika 61 (3) , 2021 2021 Citations: 42
Coverage with evidence development schemes for medical devices in Europe: characteristics and challenges C Federici, V Reckers-Droog, O Ciani, F Dams, B Grigore, Z Kaló, ... The European Journal of Health Economics 22 (8), 1253-1273 , 2021 2021 Citations: 39
Fruit quality of some rose species native in Hungary S Kovacs, MG Tóth, G Facsar Eucarpia symposium on Fruit Breeding and Genetics 538, 103-108 , 1999 1999 Citations: 37
Quo vadis HTA for medical devices in Central and Eastern Europe? Recommendations to address methodological challenges R Daubner-Bendes, S Kovács, M Niewada, M Huic, M Drummond, ... Frontiers in public health 8, 612410 , 2021 2021 Citations: 33
Regional effects of the COVID-19 pandemic and policy responses in Hungary SZ Kovács, B Koós, A Uzzoli, B Páger, I Egyed R-Economy. 2020. Vol. 6. Iss. 3 6 (3), 208-221 , 2020 2020 Citations: 32
Cost-effectiveness analysis of invasive EEG monitoring in drug-resistant epilepsy S Kovács, M Tóth, J Janszky, T Doczi, D Fabó, I Boncz, L Botz, ... Epilepsy & Behavior 114, 107488 , 2021 2021 Citations: 31
A koronavírus-járvány jelenlegi és várható egészségkockázatainak területi különbségei Magyarországon= Present and Future Health Risks and Their Regional Differences in Hungary … SZ Kovács, A Uzzoli Tér és Társadalom 34 (2), 155-170 , 2020 2020 Citations: 30
New sphinctozoan sponges from the North Hungarian Triassic S Kovács N. Jb. Geol. PalaČont. Mh 11, 685-697 , 1978 1978 Citations: 30
Increasing protandry in the spring migration of the Pied Flycatcher ( Ficedula hypoleuca ) in Central Europe A Harnos, Á Nóra, S Kovács, Z Lang, T Csörgő Journal of Ornithology 156 (2), 543-546 , 2015 2015 Citations: 28
Települési önkormányzatokat érintő bevételkiesések a járványhelyzetben= Revenue Losses of Local Governments During Pandemia SZ Kovács Tér és Társadalom 34 (2), 189-194 , 2020 2020 Citations: 26
Repetitive transcranial magnetic stimulation may be a cost-effective alternative to antidepressant therapy after two treatment failures in patients with major depressive disorder A Zemplényi, J Józwiak-Hagymásy, S Kovács, D Erdősi, I Boncz, T Tényi, ... BMC psychiatry 22 (1), 437 , 2022 2022 Citations: 24
Epilógus: Az új koronavírus-járvány társadalmi-gazdasági hatásai és ezek területi következményei B Koós, SZ Kovács, B Páger, A Uzzoli Közgazdaság-és Regionális Tudományi Kutatóközpont Regionális Kutatások Intézete , 2020 2020 Citations: 24
Irradiation of meat products, chicken and use of irradiated spices for sausages IF Kiss, J Beczner, GY Zachariev, S Kovacs International Journal of Radiation Applications and Instrumentation. Part C … , 1990 1990 Citations: 24
A magyarhoni protestans egyhaz törtenete... Farkas Jozseph, Kovacs Sändor es Pokoly Jozsef közremüködesevel.(Geschichte der ungarischen protestantischen Kirche.) hung. M Zsilinszky, J Farkas, S Kovacs, J Pokoly Athenaeum , 1907 1907 Citations: 22
Implementation of coverage with evidence development schemes for medical devices: A decision tool for late technology adopter countries S Kovács, Z Kaló, R Daubner‐Bendes, K Kolasa, R Hren, T Tesar, ... Health economics 31, 195-206 , 2022 2022 Citations: 21
